Literature DB >> 10872208

The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro.

L Y Foo1, Y Lu, A B Howell, N Vorsa.   

Abstract

Ethyl acetate extracts of Sephadex LH20-purified proanthocyanidins of American cranberry (Vaccinium macrocarpon Ait.) exhibited potent biological activity by inhibiting adherence of uropathogenic isolates of P-fimbriated Escherichia coli bacteria to cellular surfaces containing alpha-Gal(1-->4)beta-Gal receptor sequences similar to those on epithelial cells in the urinary tract. The chemical structures of the proanthocyanidins were determined by 13C NMR, electrospray mass spectrometry, matrix-assisted laser absorption time-of-flight mass spectrometry and by acid catalyzed degradation with phloroglucinol. The proanthocyanidin molecules consisted predominantly of epicatechin units with mainly DP of 4 and 5 containing at least one A-type linkage. The procyanidin A2 was the most common terminating unit occurring about four times as frequently as the epicatechin monomer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10872208     DOI: 10.1016/s0031-9422(99)00573-7

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  58 in total

1.  MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention.

Authors:  Laura A Kresty; Jennifer Clarke; Kristin Ezell; Amy Exum; Amy B Howell; Toumy Guettouche
Journal:  J Carcinog       Date:  2011-12-22

2.  Anti-Porphyromonas gingivalis and anti-inflammatory activities of A-type cranberry proanthocyanidins.

Authors:  Vu Dang La; Amy B Howell; Daniel Grenier
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

3.  Coumaroyl iridoids and a depside from cranberry (Vaccinium macrocarpon).

Authors:  Allison Turner; Shao-Nong Chen; Dejan Nikolic; Richard van Breemen; Norman R Farnsworth; Guido F Pauli
Journal:  J Nat Prod       Date:  2007-02-02       Impact factor: 4.050

4.  Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women.

Authors:  T Kontiokari; K Sundqvist; M Nuutinen; T Pokka; M Koskela; M Uhari
Journal:  BMJ       Date:  2001-06-30

5.  Cranberry-derived proanthocyanidins prevent formation of Candida albicans biofilms in artificial urine through biofilm- and adherence-specific mechanisms.

Authors:  Hallie S Rane; Stella M Bernardo; Amy B Howell; Samuel A Lee
Journal:  J Antimicrob Chemother       Date:  2013-10-10       Impact factor: 5.790

6.  Oral consumption of cranberry juice cocktail inhibits molecular-scale adhesion of clinical uropathogenic Escherichia coli.

Authors:  Yuanyuan Tao; Paola A Pinzón-Arango; Amy B Howell; Terri A Camesano
Journal:  J Med Food       Date:  2011-04-11       Impact factor: 2.786

7.  Expression, modulation, and clinical correlates of the autophagy protein Beclin-1 in esophageal adenocarcinoma.

Authors:  Katherine M Weh; Amy B Howell; Laura A Kresty
Journal:  Mol Carcinog       Date:  2015-11-19       Impact factor: 4.784

Review 8.  Cranberry and urinary tract infections.

Authors:  David R P Guay
Journal:  Drugs       Date:  2009       Impact factor: 9.546

9.  Cranberry (Vaccinium macrocarpon) oligosaccharides decrease biofilm formation by uropathogenic Escherichia coli.

Authors:  Jiadong Sun; Jannie P J Marais; Christina Khoo; Kerry LaPlante; Rebecca M Vejborg; Michael Givskov; Tim Tolker-Nielsen; Navindra P Seeram; David C Rowley
Journal:  J Funct Foods       Date:  2015-08       Impact factor: 4.451

10.  Comparative study of chromatographic medium-associated mass and potential antitumor activity loss with bioactive extracts.

Authors:  Sandipan Datta; Yu-Dong Zhou; Dale G Nagle
Journal:  J Nat Prod       Date:  2013-02-26       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.